LNX2
Ligand of Numb protein X 2
Also known as: LNX2_HUMAN, MGC46315, PDZRN1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N448
- Gene
- LNX2
- Ensembl
- ENSG00000139517
- Chromosome
- 13
- Canonical length
- 690 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Plasma membrane,Cytosol
OverviewNCBI Gene
Predicted to enable ubiquitin-protein transferase activity. Predicted to act upstream of or within neural precursor cell proliferation and neuron differentiation. Predicted to be located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
690 residues, UniProt reviewed canonical sequence.
>Q8N448|LNX2
1 MGTTSDEMVS VEQTSSSSLN PLCFECGQQH WTRENHLYNY QNEVDDDLVC HICLQPLLQP
61 LDTPCGHTFC YKCLRNFLQE KDFCPLDRKR LHFKLCKKSS ILVHKLLDKL LVLCPFSSVC
121 KDVMQRCDLE AHLKNRCPGA SHRRVALERR KTSRTQAEIE NENGPTLLDP AGTLSPEADC
181 LGTGAVPVER HLTSASLSTW SEEPGLDNPA FEESAGADTT QQPLSLPEGE ITTIEIHRSN
241 PYIQLGISIV GGNETPLINI VIQEVYRDGV IARDGRLLAG DQILQVNNYN ISNVSHNYAR
301 AVLSQPCNTL HLTVLRERRF GNRAHNHSDS NSPREEIFQV ALHKRDSGEQ LGIKLVRRTD
361 EPGVFILDLL EGGLAAQDGR LSSNDRVLAI NGHDLKYGTP ELAAQIIQAS GERVNLTIAR
421 PGKPQPGNTI REAGNHSSSS QHHTPPPYYS RPSSHKDLTQ CVTCQEKHIT VKKEPHESLG
481 MTVAGGRGSK SGELPIFVTS VPPHGCLARD GRIKRGDVLL NINGIDLTNL SHSEAVAMLK
541 ASAASPAVAL KALEVQIVEE ATQNAEEQPS TFSENEYDAS WSPSWVMWLG LPSTLHSCHD
601 IVLRRSYLGS WGFSIVGGYE ENHTNQPFFI KTIVLGTPAY YDGRLKCGDM IVAVNGLSTV
661 GMSHSALVPM LKEQRNKVTL TVICWPGSLVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LNX2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- liver: 19 nTPM
- pancreas: 18 nTPM
- duodenum: 13 nTPM
- small intestine: 13 nTPM
- testis: 12 nTPM
- lung: 11 nTPM
Single-cell type
- podocytes: 244 nCPM
- alveolar cells type 1: 210 nCPM
- alveolar cells type 2: 208 nCPM
- transitional alveolar cells: 185 nCPM
- esophageal apical cells: 143 nCPM
- pancreatic acinar cells: 137 nCPM
Immune cell
- basophil: 2 nTPM
- NK-cell: 1.1 nTPM
- T-reg: 1 nTPM
- eosinophil: 0.9 nTPM
- MAIT T-cell: 0.7 nTPM
- memory CD8 T-cell: 0.7 nTPM
Brain region
- choroid plexus: 15 nTPM
- cerebellum: 12 nTPM
- hypothalamus: 6.6 nTPM
- cerebral cortex: 5.9 nTPM
- hippocampal formation: 5.7 nTPM
- thalamus: 5.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.71
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LNX2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LNX2 as an antibody target. Whether an autoantibody or antibody against LNX2 could matter depends on whether native LNX2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LNX2 is annotated at the cell surface, where native LNX2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label LNX2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...